Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2
Brigitte Müller‐Hilke, Franz Mai, Michael Müller, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 322-322
Open Access | Times Cited: 10

Showing 10 citing articles:

NVX-CoV2373 induces humoral and cellular immune responses that are functionally comparable to vector and mRNA-based vaccines
Franz Mai, Marcel Kordt, Wendy Bergmann‐Ewert, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
The type of the first prime/boost vaccine against SARS-CoV-2 exerts long-term effects on the humoral immune response
Franz Mai, Emil C. Reisinger, Brigitte Müller‐Hilke
Clinical Immunology (2025) Vol. 278, pp. 110523-110523
Open Access
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium
Bas Calcoen, Nico Callewaert, Aline Vandenbulcke, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1257-1257
Open Access | Times Cited: 7
The varying extent of humoral and cellular immune responses to either vector- or RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent of infection
Franz Mai, Wendy Bergmann, Emil C. Reisinger, et al.
Journal of Virology (2024) Vol. 98, Iss. 4
Open Access | Times Cited: 1
Vaccine-Induced T-Cell and Antibody Responses at 12 Months after Full Vaccination Differ with Respect to Omicron Recognition
Franz Mai, Johann Volzke, Emil C. Reisinger, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1563-1563
Open Access | Times Cited: 5
Binding and neutralizing antibody levels and vaccine efficacy/effectiveness compared between heterologous and homologous primary series COVID-19 vaccination: A systematic review and meta-analysis
Nasikarn Angkasekwinai, Juthamas Prawjaeng, Pattara Leelahavarong, et al.
Asian Pacific Journal of Allergy and Immunology (2022)
Open Access | Times Cited: 4
A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
Peter Lorenz, Felix Steinbeck, Franz Mai, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France
Alice Casenaz, Sandrine Grosjean, Serge Aho, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 2
Antibody titers of individuals vaccinated for COVID-19: A systematic review
Aminoddin M Domado, Homobono Jacob F Adaza, Andrea Pauline Nicole C Beltran, et al.
Journal of Biosciences (2023) Vol. 48, Iss. 3
Closed Access
An Evaluation of Serological Tests to Determine Postvaccinal Immunity to SARS-CoV-2 by mRNA Vaccines
Graciela Iglesias García, Ángel Díaz Rodríguez, Beatriz Díaz Fernández, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7534-7534
Open Access
Page 1

Scroll to top